✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-09

Switching From Ozempic or Wegovy to Compounded Semaglutide: An Honest Guide

What really changes, what stays the same, and why the move from brand-name semaglutide to a compounded version should always run through a physician.

Many people switch from brand-name Ozempic or Wegovy to compounded semaglutide, usually to lower their monthly cost, and the transition should always be managed by a physician. Compounded semaglutide contains the same active ingredient, but it is prepared by licensed U.S. pharmacies and is not FDA-approved, not brand-identical, and not reviewed by the FDA. A medical review determines whether switching makes sense for you.

A licensed compounding pharmacy lab

Why People Consider the Switch

Cost is the main driver. Brand-name Ozempic and Wegovy are FDA-approved medications, but without insurance coverage their monthly price puts them out of reach for many people, and insurers often decline to cover semaglutide when it is prescribed for weight loss rather than diabetes. When coverage is denied or a deductible resets, patients start looking for a sustainable alternative.

Compounded semaglutide is typically far less expensive. At New Hope Weight Loss, physician-supervised compounded semaglutide starts at $166 per month, and compounded tirzepatide starts at $233 per month if the physician determines a different GLP-1 medication is a better fit.

What Changes When You Switch

The most important change is regulatory status. Compounded semaglutide is prepared by licensed U.S. pharmacies, and it is not FDA-approved, not brand-identical, and not reviewed by the FDA. Brand-name Ozempic and Wegovy go through FDA review as finished products; compounded versions do not. That is a real difference, and any clinic that glosses over it is not being straight with you.

Ready to start?

$199 Skeptics' Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

What Stays the Same

The active ingredient is still semaglutide, the injection is still once weekly, and the same principle of gradual dose titration applies. Common GLP-1 side effects such as nausea, constipation, and reduced appetite follow the same general pattern, and the fundamentals of nutrition, protein intake, and regular movement matter just as much as before. Because the compounded product is not brand-identical, your physician monitors how you respond after the transition rather than assuming everything carries over automatically.

How a Physician-Managed Transition Works

Never switch medications on your own. At New Hope Weight Loss in Costa Mesa, the process starts with a $119 medical review with Dr. Anjmun Sharma, MD, in person or by telehealth. She reviews your current dose, how long you have been on it, your response, your side effects, and your overall health history, then decides whether a switch is appropriate and at what dose to begin.

Some patients also use the clinic's $199 one-month Skeptics' Trial, which includes a free B-12/lipotropic injection, to evaluate the program for a month before committing. Whatever the path, the timing of your first compounded dose, the titration schedule, and any future medication changes remain decisions made with your physician, never on your own.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Call (657) 837-3342

Frequently asked questions

Is compounded semaglutide the same as Ozempic or Wegovy?

No. It contains the same active ingredient, semaglutide, but it is prepared by licensed U.S. pharmacies and is not FDA-approved, not brand-identical, and not reviewed by the FDA.

Why do people switch from brand-name Ozempic or Wegovy to compounded semaglutide?

Cost is the most common reason. At New Hope Weight Loss, compounded semaglutide starts at $166 per month, which is often far less than paying for a brand-name pen without insurance coverage.

Can I switch from Ozempic to compounded semaglutide on my own?

No. Switching is always a medical decision. Dr. Anjmun Sharma, MD reviews your current dose, response, and health history during a $119 medical review before any change is made.

Will my dose stay the same when I switch to compounded semaglutide?

Not necessarily. Your physician decides the starting dose and titration schedule based on your current dose and how you have responded, rather than assuming a one-to-one carryover.

Is there a low-commitment way to try compounded semaglutide after Ozempic?

Yes. New Hope Weight Loss offers a $199 one-month Skeptics' Trial that includes a free B-12/lipotropic injection, with physician supervision throughout.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.